# The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

> **NCT00607035** · PHASE4 · COMPLETED · sponsor: **Jichi Medical University** · enrollment: 220 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Olmesartan medoxomil ＋Azelnidipine
- **DRUG:** Olmesartan medoxomil + Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00607035
- **Lead sponsor:** Jichi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-05
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2008-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607035, "The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00607035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*